MYELOPEROXIDASE-MEDIATED ACTIVATION OF XENOBIOTICS BY HUMAN-LEUKOCYTES

被引:39
作者
HOFSTRA, AH
UETRECHT, JP
机构
[1] UNIV TORONTO,FAC PHARM,TORONTO M5S 1A1,ONTARIO,CANADA
[2] UNIV TORONTO,FAC MED,TORONTO M5S 1A1,ONTARIO,CANADA
[3] SUNNYBROOK MED CTR,TORONTO M4N 3M5,ONTARIO,CANADA
[4] UNIV TORONTO,CTR DRUG SAFETY RES,TORONTO M5S 1A1,ONTARIO,CANADA
[5] UNIV TORONTO,FAC PHARM,TORONTO M5S 2S2,ON,CANADA
关键词
IDIOSYNCRATIC; IMMUNE-MEDIATED; MYELOPEROXIDASE; NEUTROPHILS; RESPIRATORY BURST;
D O I
10.1016/0300-483X(93)90066-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Peripheral blood leukocytes contain a variety of enzymes that are capable of metabolising xenobiotics. The enzyme myeloperoxidase (MPO) appears to be the most important for drug metabolism. MPO is a peroxidase/oxidase and generates the powerful oxidant hypochlorous acid. MPO- or MPO-generated oxidants are capable of oxidizing a wide variety of compounds and a broad range of functional groups, especially those that contain nitrogen and sulfur. Leukocytes have a role in immune response; therefore, reactive intermediates generated by leukocyte metabolism of xenobiotics may have a role in idiosyncratic drug reactions, particularly those that are immune-mediated such as drug-induced lupus or agranulocytosis.
引用
收藏
页码:221 / 242
页数:22
相关论文
共 112 条